Loading company…
Quastella develops AI tools for cell culture and cell image analysis.
Quastella's Cell Culture DX technology helps users manage cell cultivation across fields including drug discovery and regenerative medicine. Its Cytometa platform supports cell image analysis. Founded in 2019, the company is based in Nagoya, Japan. It raised seed funding from Incubate Fund and SSS Capital in October 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in